Skip to main content
Open Access Publications from the University of California


UCLA Previously Published Works bannerUCLA

Identification and validation of genes affecting aortic lesions in mice.

  • Author(s): Yang, Xia;
  • Peterson, Larry;
  • Thieringer, Rolf;
  • Deignan, Joshua L;
  • Wang, Xuping;
  • Zhu, Jun;
  • Wang, Susanna;
  • Zhong, Hua;
  • Stepaniants, Serguei;
  • Beaulaurier, John;
  • Wang, I-Ming;
  • Rosa, Ray;
  • Cumiskey, Anne-Marie;
  • Luo, Jane Ming-Juan;
  • Luo, Qi;
  • Shah, Kashmira;
  • Xiao, Jianying;
  • Nickle, David;
  • Plump, Andrew;
  • Schadt, Eric E;
  • Lusis, Aldons J;
  • Lum, Pek Yee
  • et al.

Published Web Location

Atherosclerosis represents the most significant risk factor for coronary artery disease (CAD), the leading cause of death in developed countries. To better understand the pathogenesis of atherosclerosis, we applied a likeli-hood-based model selection method to infer gene-disease causality relationships for the aortic lesion trait in a segregating mouse population demonstrating a spectrum of susceptibility to developing atherosclerotic lesions. We identified 292 genes that tested causal for aortic lesions from liver and adipose tissues of these mice, and we experimentally validated one of these candidate causal genes, complement component 3a receptor 1 (C3ar1), using a knockout mouse model. We also found that genes identified by this method overlapped with genes progressively regulated in the aortic arches of 2 mouse models of atherosclerosis during atherosclerotic lesion development. By comparing our gene set with findings from public human genome-wide association studies (GWAS) of CAD and related traits, we found that 5 genes identified by our study overlapped with published studies in humans in which they were identified as risk factors for multiple atherosclerosis-related pathologies, including myocardial infarction, serum uric acid levels, mean platelet volume, aortic root size, and heart failure. Candidate causal genes were also found to be enriched with CAD risk polymorphisms identified by the Wellcome Trust Case Control Consortium (WTCCC). Our findings therefore validate the ability of causality testing procedures to provide insights into the mechanisms underlying atherosclerosis development.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View